Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Protalix BioTherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +8 vs. Q4 2022
- Shares held
- 2.94M
- −630.2K (−17.7%) vs. Q4 2022
- Total value
- $6.15M
- +$1.28M (+26.2%) vs. Q4 2022
- New holders
- 11
- 7 more added
- Sold out
- 3
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $30.9M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $11.9M |
| Q4 2023 | 66 | $17.6M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.45M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.24M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 39 | $82 | 0.00% | −2,928−98.7% | Reduced |
| Federation des caisses Desjardins du Quebec | 250 | $525 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 601 | $1.26K | 0.00% | +101+20.2% | Added |
| Tower Research Capital LLC (TRC) | 1,602 | $3.00K | 0.00% | +1,602 | New |
| Barclays PLC | 2,000 | $4.20K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 3,744 | $7.00K | 0.00% | −2,256−37.6% | Reduced |
| Truvestments Capital LLC | 3,880 | $8.15K | 0.00% | +3,880 | New |
| UBS Group AG | 4,691 | $9.85K | 0.00% | +4,571+3,809.2% | Added |
| Federated Hermes, Inc. | 5,761 | $12.1K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6,100 | $12.7K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6,000 | $13.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,309 | $21.0K | 0.00% | +10,309 | New |
| Altshuler Shaham Ltd | 12,142 | $25.5K | 0.00% | −336−2.7% | Reduced |
| Lido Advisors, LLC | 15,554 | $32.7K | 0.00% | +15,554 | New |
| Aptus Capital Advisors, LLC | 16,010 | $33.6K | 0.00% | +16,010 | New |
| Sculptor Capital LP | 19,100 | $40.1K | 0.00% | +19,100 | New |
| Two Sigma Advisers, LP | 19,900 | $41.8K | 0.00% | −700−3.4% | Reduced |
| Two Sigma Securities, LLC | 20,760 | $43.6K | 0.00% | +20,760 | New |
| CIBC World Markets Inc. | 25,000 | $52.0K | 0.00% | −11,000−30.6% | Reduced |
| Capital Performance Advisors LLP | 25,974 | $54.5K | 0.03% | 00.0% | Unchanged |
| IHT Wealth Management, LLC | 26,800 | $56.3K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 34,064 | $71.5K | 0.01% | +34,064 | New |
| Jane Street Group, LLC | 39,665 | $83.3K | 0.00% | −52,554−57.0% | Reduced |
| Commonwealth Equity Services, LLC | 50,100 | $105.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 82,176 | $172.6K | 0.00% | +73,959+900.1% | Added |
| Millennium Management LLC | 86,698 | $182.0K | 0.00% | +86,698 | New |
| BlackRock Inc. | 116,143 | $243.9K | 0.00% | +14,250+14.0% | Added |
| Bridgeway Capital Management, LLC | 133,790 | $281.0K | 0.01% | 00.0% | Unchanged |
| Marshall Wace, LLP | 150,358 | $315.8K | 0.00% | +150,358 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 158,703 | $333.3K | 0.00% | +158,703 | New |
| Two Sigma Investments, LP | 194,094 | $407.6K | 0.00% | +183,968+1,816.8% | Added |
| Citadel Advisors LLC | 211,548 | $444.3K | 0.00% | +87,241+70.2% | Added |
| Meitav Dash Investments Ltd | 244,332 | $493.6K | 0.01% | −150−0.1% | Reduced |
| Renaissance Technologies LLC | 1,209,750 | $2.54M | 0.00% | +985,147+438.6% | Added |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −2,413,487−100.0% | Sold out |
| Smith, Salley & Associates | 0 | $0 | 0.00% | −12,048−100.0% | Sold out |
| Ten Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |